Showing 2031-2040 of 2736 results for "".
- New Leadership Roles at Dominion Aesthetic Technologieshttps://modernaesthetics.com/news/new-leadership-roles-at-dominion-aesthetic-technologies/2472975/Cooper Collins will lead
- ISHRS Survey: Brad Pitt, Eva Longoria Top List of Most-Desired Celebrity Lockshttps://modernaesthetics.com/news/brad-pitt-eva-longoria-top-list-of-most-desired-best-celebrity-locks/2472949/When it comes to celebrity hair, it’s Brad Pitt and Eva Longoria’s locks that are most admired, according to a
- Updates on Aesthetic Meeting Cancellations Due to COVID-19https://modernaesthetics.com/news/aesthetic-meeting-cancellation-updates/2472895/In an attempt to help slow the continuing spread of the COVID-19 virus, many industry societies have cancelled or postponed conferences. The Aesthetics Meeting 2020 has postponed its meeting, which was scheduled to start on April 25 in Las Vegas. Find more inforamtion about the postpone
- Ortho Dermatologics' Dermatology.com Site Offers Telemedicine Option, Including for Aginghttps://modernaesthetics.com/news/ortho-dermatologics-dermatologycom-site-offers-telemedicine-option-including-for-aging/2472884/
- Alma’s Opus Plasma Debuts in North Americahttps://modernaesthetics.com/news/almas-opus-plasma-debuts-in-north-america/2472871/Alma, Inc. is launching Opus in North America. Opus is a new platform featuring the company's proprietary high-frequency unipolar radio-frequency technology, Opus Plasma. Opus Plasma is the first fractional plasma technology to enter the f
- It's A Deal: Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernaesthetics.com/news/its-a-deal-baring-private-equity-asia-agrees-to-acquire-lumenis/2472848/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr
- AAFPRS’s Face To Face and Break The Silence Foundation Join Forces to Aid Domestic Abuse Survivorshttps://modernaesthetics.com/news/aafprss-face-to-face-and-break-the-silence-foundation-join-forces-to-aid-domestic-abuse-survivors/2472825/The American Academy of Facial Plastic and Reconstructive Surgery’s FACE TO FACE humanitarian program is partnering with Break the Silence Foundation (BTSF), a non-profit organization that provides p
- Daily Almond Consumption May Reduce Facial Wrinkleshttps://modernaesthetics.com/news/daily-almond-consumption-may-reduce-facial-wrinkles-1/2472824/Snacking on almonds may help postmenopausal women smooth wrinkles from the inside out, according to a new study funded by the Almond Board of California. In this 16-week randomized con
- Hologic's Cynosure Division Expands Body Contouring Linehttps://modernaesthetics.com/news/hologics-cynosure-division-expands-body-contouring-line/2471877/